Haibo AND Gong

Dr. Haibo AND Gong


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2024 in Medicine
Verified
Journal Article
Open access
YLYuan Luo
Yuan Luo
XCXiao Chen
Xiao Chen
XSXiaocong Shen
Xiaocong Shen
LCLi Chen
Li Chen
HGHaibo AND Gong
Haibo AND Gong
Objective: To evaluate the clinical effectiveness of the Kinesio tape in the treatment of patellofemoral pain syndrome (PFPS) by meta-analysis. Methods: Two investigators independently conducted an electronic literature search to assess the outcomes of intramuscular patches for PFPS. Electronic databases included PubMed, Embase, Web of Science, Cochrane Library, Wanfang Database, Chinese Journal Full Text Database (CNKI), and Wipo Database from November 2023. Extracted inclusion indicators included pain score VAS or NRS, knee function assessment knee pain syndrome (Kujala) score, and knee symptom score Lysholm knee score scale. Data were extracted and then meta-analyzed using Review Manager 5.3 software and Stata 17.0 software. Result: Fourteen studies were included, all of which were randomized controlled studies. The results showed that short-term pain relief was superior in the Kinesio tape (KT) group compared with the control group, with a statistically significant difference in the results (MD = −1.54, 95% CI [−2.32, −0.76], P = .0001); medium-term pain relief was superior in the KT group compared with the control group, with a statistically significant difference in the results (MD = −0.84, 95% CI [−1.50, −0.18], P = .01); long-term pain relief in the KT group was better than the control group, with statistically different results (MD = −0.56, 95% CI [−0.98, −0.13], P < .00001). In contrast, there was no significant difference between the KT group and the control group in the assessment of knee function (MD = −0.98, 95% CI [−4.03, 2.06], P = .03), and there was no significant difference between the KT group and the control group in the Lysholm knee score scale score of knee symptoms (MD = 4.18, 95% CI [−6.70, 15.05], P = .45). Conclusion: Kinesio taping can effectively relieve the pain of PFPS, but has no significant effect on the improvement of knee joint function and symptoms.

14 November 2025 in Medicine
Verified
Journal Article
Open access
XCXiao Chen
Xiao Chen
JCJing Chen
Jing Chen
HGHaibo AND Gong
Haibo AND Gong
YFYuanhe Fan
Yuanhe Fan
YLYuan Luo
Yuan Luo
Remnant cholesterol (RC) and high-sensitivity C-reactive protein are metabolic syndrome (MetS) risk factors. The Remnant Cholesterol Inflammation Index (RCII), combining both, reflects metabolic and inflammatory risk. This study assessed RCII’s association with long-term MetS risk in US (National Health and Nutrition Examination Survey [NHANES]) and Chinese (China Health and Retirement Longitudinal Study [CHARLS]) populations. We analyzed 3743 NHANES and 9616 CHARLS participants. RCII quartiles were created. Associations with MetS risk were evaluated using multivariable logistic regression (adjusting for covariates) and restricted cubic spline (RCS) regression for dose–response. Predictive performance was assessed via the receiver operating characteristic and decision curve analysis curves. MetS prevalence was 40.34% (NHANES) and 59.31% (CHARLS). NHANES (US): each 1-unit RCII increase was associated with a 3% higher MetS risk (odds ratio [OR] = 1.03, 95% confidence interval [CI]: 1.02–1.03, P < .0001). Participants in the highest RCII quartile (Q4) had a 6.98-fold increased risk compared to Q1 (OR = 6.98, 95% CI: 5.18–9.41, P < .0001). RCS revealed a nonlinear inverse “J”-shaped relationship; risk increased significantly below an inflection point (RCII = 11.175) (OR = 1.164, P < .0001) but plateaued above it ( P = .9307). Race and hypertension status significantly modified the association. CHARLS (China): each 1-unit RCII increase was associated with a 0.3% higher MetS risk (OR = 1.003, 95% CI: 1.003–1.004, P < .0001). Q4 participants had a 5.73-fold higher risk versus Q1 (OR = 5.73, 95% CI: 4.90–6.69, P < .0001). RCS also showed an inverse “J”-shaped relationship with an inflection point (RCII = 59.107). Risk increased significantly below 59.107 (OR = 1.029, P < .0001) and weakened above it ( P = .0979). Gender, age, nationality, marital status, BMI, diabetes, smoking, stroke, and chronic kidney disease were significant interaction factors. Elevated RCII levels are significantly associated with increased MetS risk in both US and Chinese populations, demonstrating a nonlinear relationship. By integrating metabolic (RC) and inflammatory (high-sensitivity C-reactive protein) risk, RCII serves as a valuable tool for MetS risk stratification and clinical decision-making. However, the cross-sectional design limits causal inference, and further prospective studies are warranted to verify this association.

29 March 2026 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
XCXiao Chen
Xiao Chen
CWChaochao Wang
Chaochao Wang
QHQi Huang
Qi Huang
YLYuan Luo
Yuan Luo
ZWZhe Wu
Zhe Wu
HGHaibo AND Gong
Haibo AND Gong
The global prevalence of cardiometabolic multimorbidity (CMM) has created a substantial health burden. The triglyceride–total cholesterol–body


20 June 2026 in Cardiovascular Diabetology
Verified
Journal Article
Open access
XCXiao Chen
Xiao Chen
CWChaochao Wang
Chaochao Wang
YLYuan Luo
Yuan Luo
QHQi Huang
Qi Huang
HGHaibo AND Gong
Haibo AND Gong
XCXiao Chen
Xiao Chen
Cardiovascular disease (CVD) is the leading cause of death globally. The C-reactive protein-triglyceride-glucose index (CTI) integrates inflammation and insulin resistance. However, research on cumulative effects and longitudinal patterns of CTI combined with body shape indices for CVD risk assessment is limited. We examined association of cumulative CTI-CVAI (CumCTI-CVAI) exposure and longitudinal patterns with new-onset CVD, heart disease, and stroke in middle-aged and older Chinese adults. Data were from the CHARLS. A two-stage design (cross-sectional screening + longitudinal validation) was employed. Cross-sectional analysis (n = 9,475) identified CTI-CVAI as the optimal composite indicator. In longitudinal analysis (n = 3,803; median follow-up 56.6 months), cumulative CTI-CVAI was calculated using time-weighted averages (2011-2015). The landmark time was set at 2015 to avoid immortal time bias. Cox regression, RCS, K-means clustering, subgroup analyses, and sensitivity analyses (lag analysis, interval deletion analysis, competing risk model, etc.) were performed. NRI and IDI were calculated. A nomogram was constructed using LASSO regression, with AUC for discrimination and calibration/DCA for clinical utility. Cross-sectional analysis identified CTI-CVAI as the optimal indicator (AUC = 0.617). In longitudinal analysis, each 1-SD increase in CumCTI-CVAI was associated with a 9% higher CVD risk (HR = 1.09, 95%CI:1.04-1.14, P < 0.001). The highest tertile had a 63% higher risk than the lowest (HR = 1.63, 95%CI:1.33-2.00). A nonlinear dose-response relationship was observed (P < 0.001; inflection point:6192.15). For secondary outcomes, each 1-SD increase in CumCTI-CVAI was associated with a 7% higher risk of heart disease (HR = 1.07, 95%CI:1.01-1.14) and a 16% higher risk of stroke (HR = 1.16, 95%CI:1.06-1.27). K-means clustering identified three exposure patterns: low-stable, moderate-stable, and high-stable. Compared to the low-stable group, the high-stable group had 68% higher CVD risk (HR = 1.68), 43% higher heart disease risk (HR = 1.43), and 133% higher stroke risk (HR = 2.33). Hierarchical NRI/IDI analysis showed that adding inflammation to TyG-CVAI significantly improved reclassification (IDI: from 0.018 to 0.090, P < 0.001). The nomogram (age, lung disease, CumCTI-CVAI) achieved AUCs of 0.618-0.638. Elevated cumulative CTI-CVAI exposure and unfavorable longitudinal patterns are independently associated with increased CVD risk in middle-aged and older Chinese adults. CTI-CVAI provides incremental predictive value beyond obesity and insulin resistance alone, supporting its potential as an adjunctive screening tool in primary care.